Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Oral Probiotics to Reduce Urinary Oxalate Excretion

NCT00587041 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00587041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00587041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Oral Probiotics to Reduce Urinary Oxalate Excretion
Lead sponsor
Mayo Clinic
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2006
Completion date
July 31, 2009
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, hyperoxaluria, nephrolithiasis